NBT-NM108

N/A

Report date: 2025/06/25 16:12:28
NME

Base Information

Drug NameNBT-NM108
Drug Alias NameNBT-NM108 (novel botanical-based fixed-combination drug)
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract > Plants extract
Mechanisms of ActionGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)ObesityPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNotitia Biotechnologies Company
China Registration ClassN/A

Develop Information

Active CompaniesRutgers UniversityNotitia Biotechnologies Company
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)ObesityPrader-Willi Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A